Pain, PostoperativePhase 4NCT06076707
Comparing Analgesic Effects of Wound Infiltration Using Bupivacaine, Tramadol, and Tramadol Plus Bupivacaine
A Phase 4 study testing bupivacain-tramadol in people with Pain, Postoperative, run by Wollo University at 1 site in Ethiopia.
Trial summary
The goal of this study's clinical trial is to compare in post-operative analgesic effectiveness of wound infiltration using bupivacaine, tramadol, and tramadol plus bupivacaine in patients undergoing elective cesarean section under spinal anesthesia. Read more about this study
- Who is it for?
- Ages 18 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pain, Postoperative
- What is being tested?
- bupivacain-tramadol
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 163 participants
- Where
- 1 siteEthiopia
- Study dates
- 30 Nov 2023to 2 Jun 2024
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Women age between 18 and 35
- ASA risk class I-II
Who cannot join
- - Chronic pain diagnosis
- ASA above II
- Comorbidities (Anemia, DM, HTN, Arthritis)
- Known allergy to bupivacaine, tramadol
- History of alcohol, opiate, or other drug abuse
- Use of preoperative anti-pain
Trial locations and contacts
1 site in 1 country.
Ethiopia1 site
Dessie comprehensive specilized hospital
Dessie, Amhara, 801103
About this study
Official title: Comparing Post-operative Analgesic Effectiveness of Wound Infiltration Using Bupivacaine, Tramadol, and Tramadol Plus Bupivacaine in Patients Undergoing Elective Cesarean Section Under Spinal Anesthesia at Dessie Comprehensive Specialized Hospital, Ethiopia 2022 a Double-Blinded Control Study.
The goal of this study's clinical trial is to compare in post-operative analgesic effectiveness of wound infiltration using bupivacaine, tramadol, and tramadol plus bupivacaine in patients undergoing elective cesarean section under spinal anesthesia. The main question the study aimed to answer is "which approach is best among the 3"
all participants need to respond to the pain severity for the data collectors and they will receive treatments accordingly There will be 3 groups in the study
- group T: for tramadol
- group B: for bupivacaine
- group TB : tramadol + bupivacaine
Read the detailed description
Source Population: All parturients who are scheduled for elective cesarean delivery under spinal anesthesia at Dessie Comprehensive Specialized Hospital
Sample size determination: since there is no previous study done with this title in the study area, we take from a previous study done by Sahmeddini et al in India in the same population. We choose the "time for the first request of analgesia" variable because we found a larger sample size with this variable using the G*Power application. Using G*Power (using version 3.1.9.2) with a power of 80% and confidence interval of 95%, we estimated 153 participants, and considering dropout and nonresponse (10% contingency) a total of 163 patients (54 in each group) would be needed.
Sampling procedure
A 5-month logbook report of the hospital showed that around 400 patients undergo elective c/s. 163 patients will be recruited with a probability of 24% until the sample size is achieved by considering the sequential patients scheduled for C/S as the sampling frame. All patients have a 50% equal chance of being included in the study. The first patient will be recruited by lottery method and then every 2nd will be included until the required sample size is completed. After informed consent is taken, eligible participants will be allocated to one of the two groups with a sealed non-transparent envelope containing the name of the study group
Data collection procedure:
4 anesthetists will be trained by the principal investigator about "how to perform their given tasks" in the research for 5 days. There will be 2 BSC anesthetists dedicated to data collection, 1 BSC anesthetist maintaining randomization and preparing the drugs, and 1 MSC anesthetist performing local infiltration. Explanation about the study and taking written informed consent will be done by the data collectors. The routine peri-operative spinal anesthesia care will be maintained and the interventional drugs will be administered at the end of the procedure before wound closure. The data collector will meet the patient in PACU for the second time and start to assess pain intensity, tramadol consumption, time for the first analgesic request as well as adverse side effects using systematically structured questionnaires and chart review. The supervisors will assist and supervise the data collection process. All data collectors will be BSc anesthetists who have three years of experience. An evaluation will be performed at eight different time points: T0, T2, T4, T6, T8, T12, T18, and T24. Collected data will be checked for completeness, accuracy, and clarity by the principal investigator and the supervisors. For measuring and comparing the intensity and prevalence of pain, NRS has been found to be reliable in a rural population irrespective of literacy status(29)
Blinding
The data collector, patient, and primary investigators will be blinded about the components of drugs in the wound infiltration. The interventional drugs will be prepared by another anesthetist who will not participate in data collection or as an investigator. He/ she will prepare an envelope that will be generated by computer software for all study participants and held sealed until the day of surgery. On the day of surgery after they change clothes the mother will pick up the envelope that will open by one anesthetist who will be responsible for writing the generated random number and letter as TB for tramadol + bupivacaine group and T for tramadol group and B for bupivacaine group.
Data quality management
Training will be given to data collectors regarding study tools, objectives of the study, rights of respondents, and confidentiality of the information. To ensure the quality of data, we will check out for completeness, accuracy, and clarity before data entry. The complete data will enter into the SPSS version 22 computer program. Data clean-up and cross-checking will before analysis.
Data processing and statistical analysis
Data will be checked, coded, entered, and analyzed by SPSS version 22 computer program. The normality of data will be checked by K using the Shapiro-Wilk normality test and homogeneity of variance by Levene's test. The presence of Outliers will also be assessed by a boxplot. Analysis of variance (ANOVA) and Kruskal-Wallis H test will be used for normally distributed continuous data and non-normally distributed or non-parametric data respectively. If these ANOVAs or Kruskal-Wallis H test e significant, then Tukey post hoc test was used to compare one group with the others. Categorical data will be analyzed using the Pearson Chisquared test. Data were expressed as a mean and standard deviation (SD) and Median (Q1-Q3). Frequency, percentages, tables, and figures will be used to summarize data. Data will be expressed in terms of mean ± SD for normally distributed data or median (interquartile range) for skewed data. P-value < 0.05 with a power of 80% is considered statistically significant.
Standard operating procedure (Anesthesia protocol) Step 1: Preparation A standard preoperative assessment will be done for all parturients one day before the surgery. All mothers will receive premedication (dexamethasone 8mg, metoclopramide 10mg, and cimetidine 200mg). All necessary equipment like anesthesia mashie, suction machine, oxygen supply, vaporizers, Pulse oximetry, ECG, BP, Capnography (if applicable), Face mask, Oro pharyngeal airway, ETT, LMA (if appropriate), Boogie or Stylet and the spinal set will be checked and prepared. Availability of inductional, relaxants, antiemetics, analgesia, Local anesthetics, and emergency drugs should be checked before the parturient enters the OR. We may not need all these equipment and drugs for SA but we may face failed spinal, high spinal, or total spinal so we should have a backup plan.
Step 2: SA administration and intra-op SA management After the mother entered the OR and is placed on the OR table, SA will be performed by one BSC anesthetist between L3-L4 interspace at sitting position by using tuffers line as a landmark with a 25 gauge spinal needle and 12.5 ml of 0.5% isobaric bupivacaine at a rate of 0.2 ml per second. Then routine intraoperative SA care will be provided for all parturients.
Step 3: Wound infiltration All interventional drugs will be prepared 10 minutes before the end of surgery in a 10cc syringe. At the end of surgery before wound closure, group T will receive 2 mg/kg tramadol, group B will receive 0.25% of 0.7ml/kg bupivacaine and TB will receive a combination of tramadol (2mg/kg and bupivacaine (0.25%, 0.7ml/kg) as wound site infiltration by MSC anesthetist. Then after checking vital signs, all parturients will transfer to PACU and will meet the data collector for the second time.
Operational definition Wound infiltration: the analgesic technique of administering local anesthetic with or without additives directly into the surgical incision at the end of the procedure.
Acute postoperative pain: is the pain experienced immediately after an operation, usually lasting for days or sometimes weeks Chronic pain: is any pain that remains or keeps coming back for more than 3 months or for longer than the expected healing time.
Chronic post-surgical pain: pain that develops after a surgical procedure that lasts for at least three months.
Postoperative pain: when patients complain about the presence of pain after an operation or any pain score other than zero within 24 hours.
Cesarean delivery: delivery of a fetus through surgical incisions made through the abdominal wall (laparotomy) and the uterine wall (hysterectomy) Elective cesarean delivery: cesarean delivery is done before the onset of labor when surgeons decided.
NRS: Is a valid pain intensity assessment tool that involves asking a patient to rate his or her pain from 0-10 (11-point scale) with the understanding that 0 is equal to no pain and 10 equal to the worst possible pain Total analgesic consumption: the total amount of analgesic drugs in milligrams used in the first 24 hours after the operation.
Time to first analgesic request: is a time in minutes measured from the end of the procedure to the time when the patient requests analgesics.
Duration of surgery: time in minutes from skin incision to end skin closure. Duration of anesthesia: a time in minutes it takes from administration of induction agent to the time a patient is intubated.
- Conditions
- Pain, Postoperative
- Being tested
- bupivacain-tramadol
- Medical subject headings
- Pain, Postoperative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
bupivacain-tramadolDrug
Comparing effectiveness of tramadol and bupivacaine for postoperative pain treatment and prevention for cesarian section
| Study group | Role | What they receive |
|---|---|---|
| Tramadol (T) group | Experimental | Participants will be infiltrated with only 200mg tramadol around the wound. Receives: Drug: bupivacain-tramadol |
| Bupivacain (B) group | Placebo comparator | participants will be infiltrated with only bupivacaine around the wound Receives: Drug: bupivacain-tramadol |
| Tramadol + bupivacain ( T+B) group | Experimental | The participants will be infiltrated with tramadol and bupivacaine which are mixed together in the same syringe. Receives: Drug: bupivacain-tramadol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Measuring pain severity
Pain severity is measured by a visual analog scale(VAS) which measures pain severity from zero to ten
Measured: starting from discharging from operation table to the 2nd day of surgery ( for 48 hours)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Oct 2023
- Study start30 Nov 2023 (estimated)
- Primary completion30 May 2024 (estimated)
- Study completion2 Jun 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pain, PostoperativeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 163 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Wollo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aynalem Befkadu Woldemichael, Wollo University
- Investigators
- Woldemichael, Principal investigator, Wollo Universty
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06076707
- Sponsor's protocol ID
- 1989156
- Status last verified
- Nov 2023
- First submitted
- 17 May 2023
- Last updated
- 7 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: we are not sure about sharing until we get the necessary materials but after we get, we are willing to share!
Study at a glance
From the registry record, last updated by the sponsor on 7 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparing Post-operative Analgesic Effectiveness of Wound Infiltration Using Bupivacaine, Tramadol, and Tramadol Plus Bupivacaine in Patients Undergoing Elective Cesarean Section Under Spinal Anesthesia at Dessie Comprehensive Specialized Hospital, Ethiopia 2022 a Double-Blinded Control Study.
- ClinicalTrials.gov ID
- NCT06076707
- Acronym / sponsor ID
- 1989156
- Conditions
- Pain, Postoperative
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 163 participants (estimated)
- Lead sponsor
- Wollo UniversityUniversity, hospital or other
- Study start
- 30 Nov 2023 (estimated)
- Primary completion
- 30 May 2024 (estimated)
- Study completion
- 2 Jun 2024 (estimated)
- First posted
- 11 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study's clinical trial is to compare in post-operative analgesic effectiveness of wound infiltration using bupivacaine, tramadol, and tramadol plus bupivacaine in patients undergoing elective cesarean section under spinal anesthesia. The main question the study aimed to answer is "which approach is best among the 3"
all participants need to respond to the pain severity for the data collectors and they will receive treatments accordingly There will be 3 groups in the study
- group T: for tramadol
- group B: for bupivacaine
- group TB : tramadol + bupivacaine
Detailed description
Source Population: All parturients who are scheduled for elective cesarean delivery under spinal anesthesia at Dessie Comprehensive Specialized Hospital
Sample size determination: since there is no previous study done with this title in the study area, we take from a previous study done by Sahmeddini et al in India in the same population. We choose the "time for the first request of analgesia" variable because we found a larger sample size with this variable using the G*Power application. Using G*Power (using version 3.1.9.2) with a power of 80% and confidence interval of 95%, we estimated 153 participants, and considering dropout and nonresponse (10% contingency) a total of 163 patients (54 in each group) would be needed.
Sampling procedure
A 5-month logbook report of the hospital showed that around 400 patients undergo elective c/s. 163 patients will be recruited with a probability of 24% until the sample size is achieved by considering the sequential patients scheduled for C/S as the sampling frame. All patients have a 50% equal chance of being included in the study. The first patient will be recruited by lottery method and then every 2nd will be included until the required sample size is completed. After informed consent is taken, eligible participants will be allocated to one of the two groups with a sealed non-transparent envelope containing the name of the study group
Data collection procedure:
4 anesthetists will be trained by the principal investigator about "how to perform their given tasks" in the research for 5 days. There will be 2 BSC anesthetists dedicated to data collection, 1 BSC anesthetist maintaining randomization and preparing the drugs, and 1 MSC anesthetist performing local infiltration. Explanation about the study and taking written informed consent will be done by the data collectors. The routine peri-operative spinal anesthesia care will be maintained and the interventional drugs will be administered at the end of the procedure before wound closure. The data collector will meet the patient in PACU for the second time and start to assess pain intensity, tramadol consumption, time for the first analgesic request as well as adverse side effects using systematically structured questionnaires and chart review. The supervisors will assist and supervise the data collection process. All data collectors will be BSc anesthetists who have three years of experience. An evaluation will be performed at eight different time points: T0, T2, T4, T6, T8, T12, T18, and T24. Collected data will be checked for completeness, accuracy, and clarity by the principal investigator and the supervisors. For measuring and comparing the intensity and prevalence of pain, NRS has been found to be reliable in a rural population irrespective of literacy status(29)
Blinding
The data collector, patient, and primary investigators will be blinded about the components of drugs in the wound infiltration. The interventional drugs will be prepared by another anesthetist who will not participate in data collection or as an investigator. He/ she will prepare an envelope that will be generated by computer software for all study participants and held sealed until the day of surgery. On the day of surgery after they change clothes the mother will pick up the envelope that will open by one anesthetist who will be responsible for writing the generated random number and letter as TB for tramadol + bupivacaine group and T for tramadol group and B for bupivacaine group.
Data quality management
Training will be given to data collectors regarding study tools, objectives of the study, rights of respondents, and confidentiality of the information. To ensure the quality of data, we will check out for completeness, accuracy, and clarity before data entry. The complete data will enter into the SPSS version 22 computer program. Data clean-up and cross-checking will before analysis.
Data processing and statistical analysis
Data will be checked, coded, entered, and analyzed by SPSS version 22 computer program. The normality of data will be checked by K using the Shapiro-Wilk normality test and homogeneity of variance by Levene's test. The presence of Outliers will also be assessed by a boxplot. Analysis of variance (ANOVA) and Kruskal-Wallis H test will be used for normally distributed continuous data and non-normally distributed or non-parametric data respectively. If these ANOVAs or Kruskal-Wallis H test e significant, then Tukey post hoc test was used to compare one group with the others. Categorical data will be analyzed using the Pearson Chisquared test. Data were expressed as a mean and standard deviation (SD) and Median (Q1-Q3). Frequency, percentages, tables, and figures will be used to summarize data. Data will be expressed in terms of mean ± SD for normally distributed data or median (interquartile range) for skewed data. P-value < 0.05 with a power of 80% is considered statistically significant.
Standard operating procedure (Anesthesia protocol) Step 1: Preparation A standard preoperative assessment will be done for all parturients one day before the surgery. All mothers will receive premedication (dexamethasone 8mg, metoclopramide 10mg, and cimetidine 200mg). All necessary equipment like anesthesia mashie, suction machine, oxygen supply, vaporizers, Pulse oximetry, ECG, BP, Capnography (if applicable), Face mask, Oro pharyngeal airway, ETT, LMA (if appropriate), Boogie or Stylet and the spinal set will be checked and prepared. Availability of inductional, relaxants, antiemetics, analgesia, Local anesthetics, and emergency drugs should be checked before the parturient enters the OR. We may not need all these equipment and drugs for SA but we may face failed spinal, high spinal, or total spinal so we should have a backup plan.
Step 2: SA administration and intra-op SA management After the mother entered the OR and is placed on the OR table, SA will be performed by one BSC anesthetist between L3-L4 interspace at sitting position by using tuffers line as a landmark with a 25 gauge spinal needle and 12.5 ml of 0.5% isobaric bupivacaine at a rate of 0.2 ml per second. Then routine intraoperative SA care will be provided for all parturients.
Step 3: Wound infiltration All interventional drugs will be prepared 10 minutes before the end of surgery in a 10cc syringe. At the end of surgery before wound closure, group T will receive 2 mg/kg tramadol, group B will receive 0.25% of 0.7ml/kg bupivacaine and TB will receive a combination of tramadol (2mg/kg and bupivacaine (0.25%, 0.7ml/kg) as wound site infiltration by MSC anesthetist. Then after checking vital signs, all parturients will transfer to PACU and will meet the data collector for the second time.
Operational definition Wound infiltration: the analgesic technique of administering local anesthetic with or without additives directly into the surgical incision at the end of the procedure.
Acute postoperative pain: is the pain experienced immediately after an operation, usually lasting for days or sometimes weeks Chronic pain: is any pain that remains or keeps coming back for more than 3 months or for longer than the expected healing time.
Chronic post-surgical pain: pain that develops after a surgical procedure that lasts for at least three months.
Postoperative pain: when patients complain about the presence of pain after an operation or any pain score other than zero within 24 hours.
Cesarean delivery: delivery of a fetus through surgical incisions made through the abdominal wall (laparotomy) and the uterine wall (hysterectomy) Elective cesarean delivery: cesarean delivery is done before the onset of labor when surgeons decided.
NRS: Is a valid pain intensity assessment tool that involves asking a patient to rate his or her pain from 0-10 (11-point scale) with the understanding that 0 is equal to no pain and 10 equal to the worst possible pain Total analgesic consumption: the total amount of analgesic drugs in milligrams used in the first 24 hours after the operation.
Time to first analgesic request: is a time in minutes measured from the end of the procedure to the time when the patient requests analgesics.
Duration of surgery: time in minutes from skin incision to end skin closure. Duration of anesthesia: a time in minutes it takes from administration of induction agent to the time a patient is intubated.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Tramadol (T) group | Experimental | Drug: bupivacain-tramadolParticipants will be infiltrated with only 200mg tramadol around the wound. |
| Bupivacain (B) group | Placebo comparator | Drug: bupivacain-tramadolparticipants will be infiltrated with only bupivacaine around the wound |
| Tramadol + bupivacain ( T+B) group | Experimental | Drug: bupivacain-tramadolThe participants will be infiltrated with tramadol and bupivacaine which are mixed together in the same syringe. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Women age between 18 and 35
- ASA risk class I-II
Key exclusion criteria (6 listed)
- - Chronic pain diagnosis
- ASA above II
- Comorbidities (Anemia, DM, HTN, Arthritis)
- Known allergy to bupivacaine, tramadol
- History of alcohol, opiate, or other drug abuse
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| bupivacain-tramadolComparing effectiveness of tramadol and bupivacaine for postoperative pain treatment and prevention for cesarian section | Drug | Bupivacain (B) group, Tramadol (T) group, Tramadol + bupivacain ( T+B) group |
Primary outcome
Measuring pain severity
Time frame: starting from discharging from operation table to the 2nd day of surgery ( for 48 hours)
Pain severity is measured by a visual analog scale(VAS) which measures pain severity from zero to ten
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Nov 2023.
- Individual participant dataSharing planned: Undecided. we are not sure about sharing until we get the necessary materials but after we get, we are willing to share!
Related trials for Pain, Postoperative
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
Recruiting
Effect of Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite on Post-Operative Endodontic Pain.
Symptomatic Irreversible Pulpitis, Symptomatic Apical Periodontitis
RecruitingPhase 2
REctus Sheath Trial
Acute Pain, Postoperative Pain, Acute
Not yet recruiting
Effect of Pectoral Nerve Block (PECS) Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post-Mastectomy Pain
Breast Cancer, Postoperative Pain
Active, not recruitingPhase 4
Effect of Dexmedetomidine on Postoperative Pain in Spinal Anesthesia for Cesarean Section at Assuit University Hospital
Cesarean Section
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Woldemichael principal investigator
Wollo Universty
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing bupivacain-tramadol in people with Pain, Postoperative, run by Wollo University at 1 site in Ethiopia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ethiopia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Aynalem Bf Woldemichael, MSC (251916583316, aynalembefkadu31@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Measuring pain severity (time frame: starting from discharging from operation table to the 2nd day of surgery ( for 48 hours)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2023.